-
Notifications
You must be signed in to change notification settings - Fork 509
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Enhanced Insulin Flexibility: Introducing U-100 and U-200 Concentration Options in Trio #440
Comments
I have a son using Lyumjev U-200 in Trio for the last 6 months or more. Doing this was challenging as many things has to be changed to do this successfully. Another challenge is that Lyumjev U-200 is "not" 200% of U-100, something the manufactorer also admits to on their webpages. Our experience is that Lyumjev U-200 is around 170% as powerful as U-100...! It should be allowed for differences between the insulin types available with U-200., both with regard to insulin brands and possibly also individual metabolism. Secondly, this work could be started with enhancing the Trio documentation regarding the use of U-200 insulin. What settings should be changed, how much and why? We have had to change the more obvious settings like:
But we have also had to change the following as well:
Other settings that might be needed to be looked at, depending on your usage:
and this makes the following settings even more important that they are correct:
The current Bolus calculator in Trio is a Nightmare for us, as it does not take the CR settings into account at all. We are looking really forward to the new bolus calculator in Trio version 1.0.0...!!! The upcoming Remote functionality in Trio and LoopFollow will also be affected by U-200, especially the Remote Bolus function where the user must remember that they ar using U-200 and manually calculate the needed Bolus (Trio provides info about needed Bolus, but multiplying that with 1.7x in your head is not always that easy - in our case). As there seems to be an increasing amount of users using U-200 insulin, supporting this directly in Trio would be very helpful for those users...! There might also be more loopers interested in using U-200 insulin, as:
As insulin resistance is increasing dramatically in the population, and using GLP-1/GIP is not always recommended when kids are still developing - any help in this area would be very helpful and welcome...! |
The claim that Lyumjev U-200 is only about 170% as potent as U-100 is not officially confirmed by Eli Lilly, but it’s a perception shared by some users based on personal experience. Lyumjev U-200 is designed to be twice as concentrated as Lyumjev U-100, meaning each unit in the U-200 version should deliver roughly the same glucose-lowering effect as in U-100, but in half the volume. However, differences in how the body absorbs and processes the U-200 concentration can lead to variability in perceived strength or effectiveness. Here are the factors contributing to this perception include: Though Lyumjev U-200 is officially intended to have the same potency per unit as U-100, these practical differences have led some to conclude it may feel closer to around 170% as potent rather than a full 200%. |
I use Lyumjev u200 and just reduced my basal rates by about 30 percent, same for ISF and my CR. If this updates does make it, I'm assuming I would have to redo all of that. TBH, I think people who are on u200 and also using an AID, would be knowledgeable enough for the right correction factors. Also, take into consideration that if someone ,who does not use anything but u100, selects u200 accidentally can really cause issues. Just a thought. |
Thanks for your thoughts on this! I use Lyumjev U200 as well, and for my setup, I set both bolus and basal rates at 50% of the U100 settings, while keeping my carb ratio (CR) and insulin sensitivity factor (ISF) unchanged. I also find the warning window helpful, as it prompts confirmation before dosage selection. |
Please see issue #264. Maybe its easier to append findings and suggestions to that and keep it all in one central issue. |
Please see #264 for this. Closing this because duplicate. Please post the observatrions there. |
To improve Trio’s flexibility and personalization, we could introduce an option allowing users to select their insulin concentration—either U-100 or U-200 insulin. This feature would provide the following benefits:
1. Personalized Dosing Precision: Users who need higher or lower concentrations for various lifestyle needs or insulin resistance can set their concentration type. Once chosen, Trio could automatically adjust the bolus and basal doses, preventing dosing errors and ensuring accurate insulin delivery.
2. Reduced Manual Calculations: By automating the adjustments based on concentration, Trio would eliminate the need for users to calculate conversions manually, enhancing convenience and safety.
3. Broader User Compatibility: Offering both U-100 and U-200 options could attract a wider range of users, accommodating those who prefer higher concentrations due to higher insulin needs or to minimize injection volumes.
This update could align with Trio’s commitment to personalized and advanced diabetes management, helping users manage insulin with greater ease and confidence.
The text was updated successfully, but these errors were encountered: